CD96 and central nervous system cancer: We found that CD96 expression was significantly higher in higher grade gliomas; when compared to that in WHO grade II and grade III gliomas, WHO grade IV glioma (glioblastoma) showed the highest expression, and the results were consistent in both TCGA dataset and CGGA dataset (Fig. 1A,B).